{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:56:34Z","timestamp":1790772994874,"version":"4.1.0"},"reference-count":178,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Gastroenterol."],"abstract":"<jats:p>Exocrine pancreatic cancer, particularly Pancreatic Ductal Adenocarcinoma, is regarded as one of the most aggressive cancers with a poor prognosis. Its bleak outlook mainly results from its silent progression, late diagnosis, and unreliable early detection methods. Globally, PC ranks among the leading causes of cancer-related deaths, and its incidence continues to increase. Because the pancreas is situated deep within the abdomen, early symptoms such as mild abdominal pain, fatigue, or weight loss are often vague. Most patients are only diagnosed after the disease has spread beyond the point where curative treatment is possible. Although surgery provides the best chance for long-term survival, only a small number of patients qualify for it at the time of initial diagnosis. Several factors increase the risk of developing PC, including chronic pancreatitis, smoking, obesity, inherited genetic mutations (like BRCA1\/2), and new-onset diabetes (NOD), which has recently gained attention as a possible early warning sign. However, widespread screening for PC isn\u2019t yet practical because the disease is relatively uncommon and there are no highly accurate, non-invasive biomarkers. The most widely used blood test, CA 19-9, often gives unreliable results, while newer molecular approaches\u2014like circulating tumor DNA, exosomal markers, microRNAs, and metabolomic profiles\u2014are still being refined. Recent advances in imaging technology, artificial intelligence, and targeted screening for high-risk individuals hold promise for catching pancreatic cancer earlier. As we advance, combining multi-omics biomarkers with precision imaging may finally make earlier diagnosis\u2014and improved survival\u2014a reality for this devastating disease.<\/jats:p>","DOI":"10.3389\/fgstr.2026.1731223","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:55:38Z","timestamp":1790769338000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Strategy for early diagnosis of pancreatic cancer"],"prefix":"10.3389","volume":"5","author":[{"given":"Ravi Kumar","family":"Sharma","sequence":"first","affiliation":[{"name":"University Institute of Biotechnology, Chandigarh University","place":["Mohali, Punjab, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpa","family":"Singh","sequence":"additional","affiliation":[{"name":"University Institute of Biotechnology, Chandigarh University","place":["Mohali, Punjab, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Central Drug Research Institute","place":["Lucknow, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Dawra","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Command Hospital","place":["Udhampur, Jammu and Kashmir, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder Singh","family":"Rana","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Postgraduate Institute of Medical Education and Research","place":["Chandigarh, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.3390\/ijms25052860","article-title":"Clinical and preclinical targeting of oncogenic pathways in PDAC: targeted therapeutic approaches for the deadliest cancer","volume":"25","author":"Jim\u00e9nez","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1049136","article-title":"Recent estimates and predictions of 5-year survival rate in patients with pancreatic cancer: a model-based period analysis","volume":"9","author":"Li","year":"2022","journal-title":"Front Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17101607","article-title":"Unraveling the burden of pancreatic cancer in the 21st century: trends in incidence, mortality, survival, and key contributing factors","volume":"17","author":"Zottl","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102539","article-title":"Imaging modalities for early detection of pancreatic cancer: current state and future research opportunities","volume":"14","author":"Farr","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B5","volume-title":"Pancreatic Cancer-Updates in Pathogenesis, Diagnosis and Therapies: Updates in Pathogenesis, Diagnosis and Therapies","author":"Gad","year":"2023"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70318","article-title":"Global trend in pancreatic cancer prevalence rates through 2040: an illness-death modeling study","volume":"13","author":"Hesami","year":"2024","journal-title":"Cancer Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/s2468-1253(16)30079-6","article-title":"Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study","volume":"1","author":"Walter","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"Jama"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13071733","article-title":"Early detection of pancreatic cancer: current advances and future opportunities","volume":"13","author":"Lin","year":"2025","journal-title":"Biomedicines"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1543112","article-title":"Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research","volume":"16","author":"Moreland","year":"2025","journal-title":"Front Pharmacol"},{"key":"B12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/B978-0-443-23523-8.00015-8","article-title":"Targeting Tregs in pancreatic ductal adenocarcinoma","volume-title":"Immune Landscape of Pancreatic Cancer Development and Drug Resistance","author":"Siegel","year":"2024"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2023.2217354","article-title":"Screening for pancreatic cancer has the potential to save lives, but is it practical","volume":"17","author":"Mazer","year":"2023","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2021.01.017","article-title":"Guidelines on management of pancreatic cysts detected in high-risk individuals: an evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements","volume":"21","author":"Dbouk","year":"2021","journal-title":"Pancreatology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.10.017","article-title":"Functional genomics in vivo reveal metabolic dependencies of pancreatic cancer cells","volume":"33","author":"Zhu","year":"2021","journal-title":"Cell Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1425","article-title":"Carcinoembryonic antigen, carbohydrate antigen 19-9, cancer antigen 125, prostate-specific antigen and other cancer markers: a primer on commonly used cancer markers","volume":"14","author":"Desai","year":"2023","journal-title":"World J Oncol"},{"key":"B17","first-page":"1377","article-title":"Clinical significance of the combination of CEA and CA 19-9 tumor markers in Malignant and benign tumors of various origins","volume":"16","author":"Jakjimoska","year":"2018"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071377","article-title":"The role of circulating tumor cells as a liquid biopsy for cancer: advances, biology, technical challenges, and clinical relevance","volume":"16","author":"Allen","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.02.012","article-title":"Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention","volume":"164","author":"Stoffel","year":"2023","journal-title":"Gastroenterology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-00317-7","article-title":"Mechanisms controlling pancreatic islet cell function in insulin secretion","volume":"22","author":"Campbell","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10061284","article-title":"A review of the diagnosis and management of premalignant pancreatic cystic lesions","volume":"10","author":"Keane","year":"2021","journal-title":"J Clin Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235577","article-title":"Gaps and opportunities in the diagnosis and treatment of pancreatic cancer","volume":"15","author":"Caban","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2020_200706n699","article-title":"Risk factors of pancreatic cancer and their possible uses in diagnostics","volume":"68","author":"Lang","year":"2021","journal-title":"Neoplasma"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/s13053-017-0069-6","article-title":"Hereditary pancreatic cancer: related syndromes and clinical perspective","volume":"15","author":"Carrera","year":"2017","journal-title":"Hered Cancer Clin Pract"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.46883\/onc.3406.0196","article-title":"Hereditary vs familial pancreatic cancer: associated genetic syndromes and clinical perspective","volume":"34","author":"Copur","year":"2020","journal-title":"Oncol"},{"key":"B26","article-title":"Heritability and genetic architecture of pancreatic cancer","volume-title":"Johns Hopkins University","author":"Chen","year":"2018"},{"key":"B27","doi-asserted-by":"publisher","first-page":"498","DOI":"10.5009\/gnl18449","article-title":"Familial pancreatic cancer and surveillance of high-risk individuals","volume":"13","author":"Matsubayashi","year":"2019","journal-title":"Gut Liver"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S172421","article-title":"Familial pancreatic cancer: current perspectives","author":"Llach","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/medsci12010012","article-title":"Hereditary cancer syndromes","volume":"14","author":"Imyanitov","year":"2023","journal-title":"World J Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030561","article-title":"Genomic features and clinical management of patients with hereditary pancreatic cancer syndromes and familial pancreatic cancer","volume":"20","author":"Ohmoto","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051115","article-title":"Lynch-like syndrome: potential mechanisms and management","volume":"14","author":"Mart\u00ednez-Roca","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","article-title":"Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium","volume":"69","author":"Goggins","year":"2020","journal-title":"Gut"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14020367","article-title":"Hereditary pancreatic cancer: advances in genetic testing, early detection strategies, and personalized management","volume":"14","author":"Blanco Abad","year":"2025","journal-title":"J Clin Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.00298","article-title":"The multicenter cancer of pancreas screening study: impact on stage and survival","volume":"40","author":"Dbouk","year":"2022","journal-title":"J Clin Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030779","article-title":"Genetics, genomics and emerging molecular therapies of pancreatic cancer","volume":"15","author":"Liu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/genes13020321","article-title":"Pancreatic cancer with mutation in BRCA1\/2, MLH1, and APC genes: phenotype correlation and detection of a novel germline BRCA2 mutation","volume":"13","author":"Vietri","year":"2022","journal-title":"Genes (Basel)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061690","article-title":"Pancreatic cancer surveillance in carriers of a germline pathogenic variant in CDKN2A","volume":"15","author":"Llach","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12881-018-0626-5","article-title":"The altered activity of P53 signaling pathway by STK11 gene mutations and its cancer phenotype in Peutz-Jeghers syndrome","volume":"19","author":"Jiang","year":"2018","journal-title":"BMC Med Genet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"484","DOI":"10.4267\/2042\/69016","article-title":"PALB2 (partner and localizer of BRCA2)","volume":"22","author":"Hanenberg","year":"2018","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2022.05.005","article-title":"Identification of high-risk germline variants for the development of pancreatic cancer: common characteristics and potential guidance to screening guidelines","volume":"22","author":"Bennett","year":"2022","journal-title":"Pancreatology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164195","article-title":"Germline PALB2 mutation in high-risk Chinese breast and\/or ovarian cancer patients","volume":"13","author":"Kwong","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jpeds.2017.03.063","article-title":"Early-onset acute recurrent and chronic pancreatitis is associated with PRSS1 or CTRC gene mutations","volume":"186","author":"Giefer","year":"2017","journal-title":"J Pediatr"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/mpa.0000000000001136","article-title":"Germline variants and risk for pancreatic cancer: a systematic review and emerging concepts","volume":"47","author":"Zhan","year":"2018","journal-title":"Pancreas"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/genes12060845","article-title":"ATM: main features, signaling pathways, and its diverse roles in DNA damage response, tumor suppression, and cancer development","volume":"12","author":"Phan","year":"2021","journal-title":"Genes (Basel)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010056","article-title":"Understanding the genetic landscape of pancreatic ductal adenocarcinoma to support personalized medicine: a systematic review","volume":"16","author":"Pantaleo","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10147-019-01494-y","article-title":"Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome","volume":"24","author":"Tamura","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.7150\/jca.20750","article-title":"Pancreatic cancer in lynch syndrome patients","volume":"8","author":"Bujanda","year":"2017","journal-title":"J Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.2139\/ssrn.4089829","article-title":"Risk factors for pancreatic cancer in patients with new-onset diabetes: a systematic review and meta-analysis","volume":"14","author":"Mellenthin","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i27.4298","article-title":"Pancreatic cancer: a review of epidemiology, trend, and risk factors","volume":"27","author":"Hu","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31608","article-title":"A case report of new-onset diabetes mellitus as an early warning sign of pancreatic ductal adenocarcinoma in an elderly patient: The earlier the diagnosis and surgery, the better the prognosis","volume":"14","author":"Bertoni","year":"2022","journal-title":"Cureus"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/mpa.0000000000001762","article-title":"Artificial intelligence and early detection of pancreatic cancer: 2020 summative review","volume":"50","author":"Kenner","year":"2021","journal-title":"Pancreas"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2025.101129","article-title":"Informatics strategies for early detection and risk mitigation in pancreatic cancer patients","volume":"60","author":"Goel","year":"2025","journal-title":"Neoplasia"},{"key":"B54","doi-asserted-by":"publisher","first-page":"dgaf319","DOI":"10.1210\/clinem\/dgaf319","article-title":"Pancreatic cancer screening in new-onset and deteriorating diabetes: Preliminary results from the PANDOME study","author":"Frank","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","article-title":"Advancing precision medicine in pancreatic cancer through bioinformatics-assisted genomic profiling and clinical stratification","volume-title":"Karolinska Institutet","author":"Malgerud","year":"2025"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.218","article-title":"Chronic pancreatitis and pancreatic cancer risk: A systematic review and meta-analysis","volume":"112","author":"Kirkeg\u00e5rd","year":"2017","journal-title":"Off J Am Coll Gastroenterol ACG"},{"key":"B57","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: Understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1517007","article-title":"Diagnosis and management of acute, chronic, and autoimmune pancreatitis","volume":"11","author":"Sharma","year":"2024","journal-title":"Front Med"},{"key":"B59","doi-asserted-by":"crossref","DOI":"10.1002\/9781119876007.ch45","article-title":"Hereditary pancreatitis and complex genetic causes","author":"Ohlsen","year":"2023","journal-title":"Pancreas Integr Textb. Basic Sci Med Surg"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000463","article-title":"Chronic pancreatitis is a risk factor for pancreatic cancer, and incidence increases with duration of disease: A systematic review and meta-analysis","volume":"13","author":"Gandhi","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1016\/j.pan.2021.05.105","article-title":"Risk of developing pancreatic cancer in patients with chronic pancreatitis","volume":"9","author":"Vujasinovic","year":"2020","journal-title":"J Clin Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.6190","article-title":"Screening for pancreatic cancer: Updated evidence report and systematic review for the US Preventive Services Task Force","volume":"322","author":"Henrikson","year":"2019","journal-title":"Jama"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.03.088","article-title":"AGA clinical practice update on pancreas cancer screening in high-risk individuals: Expert review","volume":"159","author":"Aslanian","year":"2020","journal-title":"Gastroenterology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/01.ogx.0000549540.69362.81","article-title":"Screening for pancreatic cancer: US Preventive Services Task Force reaffirmation recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"Jama"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164644","article-title":"Diagnostics and management of pancreatic cystic lesions\u2014New techniques and guidelines","volume":"13","author":"Rogowska","year":"2024","journal-title":"J Clin Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12664-022-01269-w","article-title":"Lower cyst fluid carcinoembryonic antigen cutoff is helpful in the differential diagnosis of mucinous versus non-mucinous pancreatic cysts","volume":"41","author":"Sharma","year":"2022","journal-title":"Indian J Gastroenterol"},{"key":"B67","volume-title":"Invasive intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma: A comparison in clinicopathology and long-term outcome","author":"Holmberg","year":"2022"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-007-0447-x","article-title":"Natural history of intraductal papillary mucinous neoplasms (IPMN): Current evidence and implications for management","volume":"12","author":"Bassi","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"B69","doi-asserted-by":"crossref","DOI":"10.1002\/9781119876007.ch86","article-title":"Natural history of cystic neoplasms: IPMN, MCN, SCN, and SPN","volume-title":"Pancreas an Integr. Textb. Basic Sci. Med. Surg","author":"Klotz","year":"2023"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.899761","article-title":"Comparison of clinicopathologic characteristics and survival outcomes between invasive IPMN and invasive MCN: A population-based analysis","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fgstr.2023.1355275","article-title":"Pancreatic cystic lesions: Aiding in the early diagnosis of pancreatic cancer","volume":"2","author":"Sharma","year":"2024","journal-title":"Front Gastroenterol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"10732748231154712","DOI":"10.1177\/10732748231154711","article-title":"Early diagnosis of pancreatic cancer: Clinical premonitions, timely precursor detection and increased curative-intent surgery","volume":"30","author":"S\u00f8reide","year":"2023","journal-title":"Cancer Control"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13040585","article-title":"The role of magnetic resonance imaging (MRI) in the diagnosis of pancreatic cystic lesions (PCLs)","volume":"13","author":"Quingalahua","year":"2023","journal-title":"Diagnostics"},{"key":"B74","article-title":"Modern medical imaging and radiation therapy","author":"Kitson","year":"2024","journal-title":"Cyber Secur Big Data| AI Open Med Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.61808\/ijmhr11","article-title":"An analysis of magnetic resonance in a cross-sectional study diagnosing pancreaticobiliary diseases with cholangiopancreatography","author":"Sameer","year":"2024","journal-title":"Innov J Med Healthc Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241263644","article-title":"Risk assessment and radiomics analysis in magnetic resonance imaging of pancreatic intraductal papillary mucinous neoplasms (IPMN)","volume":"31","author":"Flammia","year":"2024","journal-title":"Cancer Control"},{"key":"B77","article-title":"Screening for pancreatic cancer in high-risk individuals","author":"Signoretti","year":"2019"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16244268","article-title":"Advances for managing pancreatic cystic lesions: Integrating imaging and AI innovations","volume":"16","author":"Seyithanoglu","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000408","article-title":"Endoscopic ultrasound (EUS) and the management of pancreatic cancer","volume":"7","author":"Yousaf","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.31557\/apjcp.2022.23.6.2151","article-title":"A comparative study of the diagnostic utility of endoscopic ultrasound-guided fine needle aspiration cytology (EUS-FNA) versus endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) in pancreatic and non-pancreatic lesions","volume":"23","author":"Yousri","year":"2022","journal-title":"Asian Pacific J Cancer Prev APJCP"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2021.06.028","article-title":"Contrast-enhanced EUS for the characterization of mural nodules within pancreatic cystic neoplasms: Systematic review and meta-analysis","volume":"94","author":"Lisotti","year":"2021","journal-title":"Gastrointest Endosc"},{"key":"B82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000455729","article-title":"Introduction to pancreatic pathology and fine-needle aspiration cytology","volume-title":"Pancreat. Tumors","author":"Dhillona","year":"2020"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040769","article-title":"Multi-omic biomarkers as potential tools for the characterisation of pancreatic cystic lesions and cancer: Innovative patient data integration","volume":"13","author":"Kane","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14316\/pmp.2021.32.1.1","article-title":"Basic physical principles and clinical applications of computed tomography","volume":"32","author":"Jung","year":"2021","journal-title":"Prog Med Phys"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13030550","article-title":"Diagnosis and management of pancreatic cysts: A comprehensive review of the literature","volume":"13","author":"Singh","year":"2023","journal-title":"Diagnostics"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-07744-w","article-title":"Low keV portal venous phase as a surrogate for pancreatic phase in a pancreatic protocol dual-energy CT: Feasibility, image quality, and lesion conspicuity","volume":"31","author":"Noda","year":"2021","journal-title":"Eur Radiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40644-020-00324-z","article-title":"Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation","volume":"20","author":"Schima","year":"2020","journal-title":"Cancer Imaging"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2021.11.008","article-title":"Sensitivity of CT, MRI, and EUS-FNA\/B in the preoperative workup of histologically proven left-sided pancreatic lesions","volume":"22","author":"Gorris","year":"2022","journal-title":"Pancreatology"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.614008","article-title":"Trimodality PET\/CT\/MRI and radiotherapy: A mini-review","volume":"10","author":"Decazes","year":"2021","journal-title":"Front Oncol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164155","article-title":"The role of positron emission tomography\/computed tomography (PET\/CT) for staging and disease response assessment in localized and locally advanced pancreatic cancer","volume":"13","author":"Ghidini","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202200718","article-title":"Nanotheranostic strategies for cancer immunotherapy","volume":"6","author":"Nguyen","year":"2022","journal-title":"Small Methods"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.am2020-761","article-title":"Comparison of 18F-Fluorodeoxyglucose (FDG) positron emission tomography\/computed tomography (18F-FDG PET\/CT) and conventional imaging (CI) for locally advanced breast cancer staging: A prospective study from a tertiary hospital cancer centre in Western Ca","author":"Chilwesa","year":"2019"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10110952","article-title":"Impact of F-18 fluorodeoxyglucose PET\/CT and PET\/MRI on initial staging and changes in management of pancreatic ductal adenocarcinoma: A systemic review and meta-analysis","volume":"10","author":"Lee","year":"2020","journal-title":"Diagnostics"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41824-018-0030-6","article-title":"PET\/MRI: A frontier in era of complementary hybrid imaging","volume":"2","author":"Musafargani","year":"2018","journal-title":"Eur J Hybrid Imaging"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.233940","article-title":"PET\/MRI versus PET\/CT for whole-body staging: Results from a single-center observational study on 1,003 sequential examinations","volume":"61","author":"Martin","year":"2020","journal-title":"J Nucl Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v12.i12.468","article-title":"Carbohydrate antigen 19-9\u2014Tumor marker: Past, present, and future","volume":"12","author":"Lee","year":"2020","journal-title":"World J Gastrointest Surg"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113234","article-title":"Recent discoveries of diagnostic, prognostic and predictive biomarkers for pancreatic cancer","volume":"12","author":"Khomiak","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1590\/0102-672020220002e1687","article-title":"Elevated CA 19-9 in an asymptomatic patient: What does it mean","volume":"35","author":"de Meira-J\u00fanior","year":"2022","journal-title":"ABCD Arq Bras Cir Dig (S\u00e3o Paulo)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100552","article-title":"Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: Results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)","volume":"7","author":"Hartlapp","year":"2022","journal-title":"ESMO Open"},{"key":"B100","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-022-01710-w","article-title":"Circulating tumor nucleic acids: Biology, release mechanisms, and clinical relevance","volume":"22","author":"Stejskal","year":"2023","journal-title":"Mol Cancer"},{"key":"B101","doi-asserted-by":"publisher","first-page":"134","DOI":"10.21037\/atm.2016.03.44","article-title":"Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we have","volume":"4","author":"Herreros-Villanueva","year":"2016","journal-title":"Ann Transl Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/cimb46040177","article-title":"Significance of TP53, CDKN2A, SMAD4 and KRAS in pancreatic cancer","volume":"46","author":"Stefanoudakis","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01047-5","article-title":"Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond","volume":"124","author":"Keller","year":"2021","journal-title":"Br J Cancer"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-22-3526","article-title":"Comprehensive ctDNA measurements improve prediction of clinical outcomes and enable dynamic tracking of disease progression in advanced pancreatic cancer","volume":"29","author":"Lapin","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/cells13010003","article-title":"A comprehensive review of the potential role of liquid biopsy as a diagnostic, prognostic, and predictive biomarker in pancreatic ductal adenocarcinoma","volume":"13","author":"Stosic","year":"2023","journal-title":"Cells"},{"key":"B106","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13098-025-01750-4","article-title":"Targeting early diagnosis and treatment of pancreatic cancer among the diabetic population: a comprehensive review of biomarker screening strategies","volume":"17","author":"Yang","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.2741\/4847","article-title":"Epigenetic alterations in cancer","volume":"25","author":"Ilango","year":"2020","journal-title":"Front Biosci"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i36.6093","article-title":"Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer","volume":"27","author":"Rah","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.07.017","article-title":"Methylated DNA in pancreatic juice distinguishes patients with pancreatic cancer from controls","volume":"18","author":"Majumder","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2019.188318","article-title":"Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker (s)","volume":"1873","author":"Carmicheal","year":"2020","journal-title":"Biochim Biophys Acta (BBA)-Reviews Cancer"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2022.06.260","article-title":"Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of pancreatic cancer","volume":"22","author":"Visser","year":"2022","journal-title":"Pancreatology"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061534","article-title":"Systemic proteome alterations linked to early stage pancreatic cancer in diabetic patients","volume":"12","author":"Peng","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215863","article-title":"TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion","volume":"546","author":"Tian","year":"2022","journal-title":"Cancer Lett"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4055-9","article-title":"Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer","volume":"18","author":"Prokopchuk","year":"2018","journal-title":"BMC Cancer"},{"key":"B115","doi-asserted-by":"publisher","first-page":"400","DOI":"10.21037\/jgo-21-910","article-title":"LRG1 in pancreatic cancer cells promotes inflammatory factor synthesis and the angiogenesis of HUVECs by activating VEGFR signaling","volume":"13","author":"Cai","year":"2022","journal-title":"J Gastrointest Oncol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-023-07904-6","article-title":"Pancreatic cancer biomarkers: oncogenic mutations, tissue and liquid biopsies, and radiomics\u2014a review","volume":"68","author":"Amaral","year":"2023","journal-title":"Dig Dis Sci"},{"key":"B117","volume-title":"Biomarkers for early detection of cancer: A systematic review","author":"Fermon","year":"2018"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/biology11060804","article-title":"Overview and update on extracellular vesicles: considerations on exosomes and their application in modern medicine","volume":"11","author":"Di Bella","year":"2022","journal-title":"Biol (Basel)"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.992929","article-title":"Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma","volume":"12","author":"Zhao","year":"2022","journal-title":"Front Oncol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810279","article-title":"The proteoglycan glypican-1 as a possible candidate for innovative targeted therapeutic strategies for pancreatic ductal adenocarcinoma","volume":"23","author":"Busato","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B121","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican1 identifies cancer exosomes and facilitates early detection of cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature"},{"key":"B122","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3978\/j.issn.2305-5839.2015.10.39","article-title":"Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer","volume":"4","author":"Herreros-Villanueva","year":"2016","journal-title":"Ann Transl Med"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2017.1281499","article-title":"Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer","volume":"18","author":"Yang","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"B124","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-023-01870-3","article-title":"Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation","volume":"22","author":"Wang","year":"2023","journal-title":"Mol Cancer"},{"key":"B125","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41392-021-00817-8","article-title":"Circulating tumor cells: biology and clinical significance","volume":"6","author":"Lin","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14020288","article-title":"Recent advances in device engineering and computational analysis for characterization of cell-released cancer biomarkers","volume":"14","author":"Abouali","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101747","article-title":"Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data","volume":"55","author":"Boyd","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B128","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1186\/s40001-025-03003-6","article-title":"Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives","volume":"30","author":"Zafar","year":"2025","journal-title":"Eur J Med Res"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55003","article-title":"The potential of salivary biomarkers in early detection of pancreatic ductal adenocarcinoma: A systematic review","volume":"16","author":"Al Balushi","year":"2024","journal-title":"Cureus"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1007\/s44174-023-00090-z","article-title":"A review on saliva-based health diagnostics: biomarker selection and future directions","volume":"2","author":"Kumari","year":"2024","journal-title":"BioMed Mater Devices"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11070891","article-title":"Salivary extracellular vesicle-associated exRNA as cancer biomarker","volume":"11","author":"Chiabotto","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16132329","article-title":"Personalized medicine in pancreatic cancer: the promise of biomarkers and molecular targeting with dr. Michael J. Pishvaian","volume":"16","author":"Cortiana","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1177\/11772719231190218","article-title":"The latest developments in using proteomic biomarkers from urine and serum for non-invasive disease diagnosis and prognosis","volume":"18","author":"Shama","year":"2023","journal-title":"biomark Insights"},{"key":"B134","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.urine.2023.10.001","article-title":"Urine biomarkers can outperform serum biomarkers in certain diseases","volume":"5","author":"Xue","year":"2023","journal-title":"Urine"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.crc-22-0190","article-title":"Diagnostic accuracy of blood-based biomarkers for pancreatic cancer: a systematic review and meta-analysis","volume":"2","author":"Kane","year":"2022","journal-title":"Cancer Res Commun"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-14-2467","article-title":"Identification of a three-biomarker panel in urine for early detection of pancreatic adenocarcinoma","volume":"21","author":"Radon","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12197","article-title":"Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes","volume":"11","author":"Leary","year":"2022","journal-title":"J Extracell Vesicles"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.7754\/clin.lab.2023.220906","article-title":"The efficacy of REG proteins as a diagnostic biomarker for pancreatic cancer: a meta-analysis","volume":"69","author":"Liu","year":"2023","journal-title":"Clin Lab"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1172\/jci97755","article-title":"Trefoil factor 1 inhibits epithelial-mesenchymal transition of pancreatic intraepithelial neoplasm","volume":"128","author":"Yamaguchi","year":"2018","journal-title":"J Clin Invest"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1002\/9781119570097.ch51","article-title":"New-onset diabetes as a harbinger of pancreatic cancer: is early diagnosis possible","author":"Andersen","year":"2021","journal-title":"Clin Pancreatol Pract Gastroenterol Surg"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-024-08839-2","article-title":"Are non-invasive multi-cancer early cancer detection tests the future","volume":"70","author":"Grady","year":"2025","journal-title":"Dig Dis Sci"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312978","article-title":"Microbiota alterations and their association with oncogenomic changes in pancreatic cancer patients","volume":"22","author":"Sammallahti","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168703","article-title":"Recent technologies towards diagnostic and therapeutic applications of circulating nucleic acids in colorectal cancers","volume":"25","author":"Chung","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.11588\/heidok.00029196","article-title":"Exploring the potential of the human microbiome for colorectal and pancreatic cancer screening","author":"Cevirgen","year":"2022"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115751","article-title":"Multi-omics model applied to cancer genetics","volume":"22","author":"Pettini","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020107206","article-title":"Tumor cell heterogeneity and its transcriptional bases in pancreatic cancer: a tale of two cell types and their many variants","volume":"40","author":"Milan","year":"2021","journal-title":"EMBO J"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-020-09952-0","article-title":"An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression","volume":"40","author":"Khan","year":"2021","journal-title":"Cancer metastasis Rev"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45784","article-title":"Exploring circulating tumor DNA (CtDNA) and its role in early detection of cancer: a systematic review","volume":"15","author":"Bittla","year":"2023","journal-title":"Cureus"},{"key":"B149","doi-asserted-by":"publisher","first-page":"17588359231157652","DOI":"10.1177\/17588359231157651","article-title":"Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma","volume":"15","author":"Topham","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-323-91810-7.00007-8","article-title":"Recent advances in transcriptomic biomarker detection for cancer","author":"Thakur","year":"2023","journal-title":"Transcr Profiling"},{"key":"B151","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41698-021-00200-4","article-title":"The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response","volume":"5","author":"Wang","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1159\/000495961","article-title":"Plasma exosomal long non-coding RNAs serve as biomarkers for early detection of colorectal cancer","volume":"51","author":"Hu","year":"2019","journal-title":"Cell Physiol Biochem"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2021.109693","article-title":"Pancreatic cancer and adaptive metabolism in a nutrient-deficient environment","volume":"46","author":"S\u0142otwi\u0144ski","year":"2021","journal-title":"Cent Eur J Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3390\/metabo10020047","article-title":"Salivary metabolomics: from diagnostic biomarker discovery to investigating biological function","volume":"10","author":"Gardner","year":"2020","journal-title":"Metabolites"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132223","article-title":"A novel multivariate index for pancreatic cancer detection based on the plasma free amino acid profile","volume":"10","author":"Fukutake","year":"2015","journal-title":"PloS One"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20230211","article-title":"Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration","volume":"96","author":"Wei","year":"2023","journal-title":"Br J Radiol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"299","DOI":"10.52843\/cassyni.ny9y74","article-title":"The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients","volume":"5","author":"Osipov","year":"2024","journal-title":"Nat Cancer"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00309","article-title":"Non-coding RNAs in pancreatic ductal adenocarcinoma","volume":"10","author":"Gong","year":"2020","journal-title":"Front Oncol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00669","article-title":"Crosstalk between long non-coding RNAs, micro-RNAs and mRNAs: deciphering molecular mechanisms of master regulators in cancer","volume":"9","author":"L\u00f3pez-Urrutia","year":"2019","journal-title":"Front Oncol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073914","article-title":"MicroRNAs in pancreatic cancer: advances in biomarker discovery and therapeutic implications","volume":"25","author":"Madadjim","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3390\/cells13110948","article-title":"The multifaceted role of miR-21 in pancreatic cancers","volume":"13","author":"Chen","year":"2024","journal-title":"Cells"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202012_24143","article-title":"MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3","volume":"23","author":"Wang","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.2174\/1389202921666191217095017","article-title":"Cell-free microRNAs as non-invasive diagnostic and prognostic biomarkers in pancreatic cancer","volume":"20","author":"Gablo","year":"2019","journal-title":"Curr Genomics"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43931","article-title":"Clinical value of circulating microRNAs in diagnosis and prognosis of pancreatic cancer: a systematic review","volume":"15","author":"Senaratne","year":"2023","journal-title":"Cureus"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5389820","article-title":"The use of biomarkers in early diagnostics of pancreatic cancer","volume":"2018","author":"Kunovsky","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.56583","article-title":"Advancements in pancreatic cancer detection: integrating biomarkers, imaging technologies, and machine learning for early diagnosis","volume":"16","author":"Daher","year":"2024","journal-title":"Cureus"},{"key":"B167","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.3390\/s24102958","article-title":"AI-driven sensing technology","volume":"24","author":"Chen","year":"2024","journal-title":"Sensors"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1159\/000546603","article-title":"Artificial intelligence-augmented imaging for early pancreatic cancer detection","author":"Antony","year":"2025","journal-title":"Visc Med"},{"key":"B169","doi-asserted-by":"publisher","first-page":"17981","DOI":"10.1038\/s41598-022-22514-4","article-title":"Artificial intelligence-based methods for fusion of electronic health records and imaging data","volume":"12","author":"Mohsen","year":"2022","journal-title":"Sci Rep"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.05.023","article-title":"Model to determine risk of pancreatic cancer in patients with new-onset diabetes","volume":"155","author":"Sharma","year":"2018","journal-title":"Gastroenterology"},{"key":"B171","article-title":"Predictive analytics in risk stratification and early diagnosis","author":"Jordan Nelson","year":"2025"},{"key":"B172","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/sla.0000000000006674","article-title":"Prognostic role of enhancing mural nodules in intraductal papillary mucinous neoplasms with high-risk stigmata","author":"Kumano","year":"2025","journal-title":"Ann Surg"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-118703","article-title":"Evaluation of AGA and Fukuoka Guidelines for EUS and surgical resection of incidental pancreatic cysts","volume":"5","author":"Lee","year":"2017","journal-title":"Endosc Int Open"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2020.083","article-title":"Cyst fluid carcinoembryonic antigen level difference between mucinous cystic neoplasms and intraductal papillary mucinous neoplasms","volume":"54","author":"K\u00f6ker","year":"2021","journal-title":"Clin Endosc"},{"key":"B175","article-title":"A lower cyst fluid CEA cut-off increases diagnostic accuracy in identifying mucinous pancreatic cystic lesions","volume":"16","author":"Jin","year":"2015","journal-title":"JOP J Pancreas"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-74942-6_2","article-title":"How to prepare cytological samples for molecular testing","volume":"70","author":"Bellevicine","year":"2017","journal-title":"J Clin Pathol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.26226\/morressier.5ebc4ac6ffea6f735881a3f6","article-title":"Surveillance of high-risk individuals for pancreatic cancer with EUS and MRI: A meta-analysis","volume":"20","author":"Kogekar","year":"2020","journal-title":"Pancreatology"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1152470","article-title":"Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review","volume":"14","author":"Di Sario","year":"2023","journal-title":"Front Genet"}],"container-title":["Frontiers in Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2026.1731223\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:55:44Z","timestamp":1790769344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2026.1731223\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":178,"alternative-id":["10.3389\/fgstr.2026.1731223"],"URL":"https:\/\/doi.org\/10.3389\/fgstr.2026.1731223","relation":{},"ISSN":["2813-1169"],"issn-type":[{"value":"2813-1169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1731223"}}